L. Foshag

发表

Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy.

A. Giuliano, T. Sarantou, A. Bilchik, 1997, Surgery.

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanoma a

R. Elashoff, R. Elashoff, R. Gupta, 1993, Annals of the New York Academy of Sciences.

Active specific immunotherapy in malignant melanoma.

R. Gupta, D. Morton, D. Hoon, 1989, Seminars in surgical oncology.

Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.

D. Morton, L. Wanek, R. Essner, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged Survival of Patients Receiving Active Immunotherapy With Canvaxin Therapeutic Polyvalent Vaccine After Complete Resection of Melanoma Metastatic to Regional Lymph Nodes

R. Elashoff, D. Morton, L. Wanek, 2002, Annals of surgery.

Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?

R. Elashoff, D. Morton, D. Hoon, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.

S. O’Day, M. Faries, S. Stern, 2016, Journal of the American College of Surgeons.

Role of sentinel lymphadenectomy in thin invasive cutaneous melanomas.

D. Morton, L. Wanek, R. Essner, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clarifying the role of fine-needle aspiration cytologic evaluation and frozen section examination in the operative management of thyroid cancer.

A. Giuliano, L. Layfield, L. Foshag, 1989, Archives of surgery.

Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms.

A. Giuliano, R. Turner, D. Morton, 1998, The cancer journal from Scientific American.

Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck.

A. Cochran, D. Morton, R. Essner, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in‐transit melanoma metastases

D. Morton, R. Essner, E. Hsueh, 1999, Cancer.

Role o f S entinel L ymphadenectomy i n T hin I nvasive Cutaneous M elanomas

D. Morton, L. Wanek, R. Essner, 2003 .

Metastasis of primary melanoma to two separate lymph node basins: Prognostic significance

D. Morton, L. Wanek, P. Dale, 2006, Annals of Surgical Oncology.

Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma

M. Faries, S. Stern, K. Huynh, 2016, Annals of Surgical Oncology.

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

R. Elashoff, D. Morton, L. Wanek, 1992, Annals of surgery.

Active immunotherapy by reinduction with a polyvalent allogeneic cell vaccine correlates with improved survival in recurrent metastatic melanoma

W. Ye, D. Morton, R. Essner, 2002, Annals of Surgical Oncology.

Advances in Brief Polyvalent Melanoma Cell Vaccine Induces Delayed-Type Hypersensitivity and in Vitro Cellular Immune Response '

D. Hoon, L. Foshag, J. A. Nizze, 2006 .

Interleukin-4 plus tumor necrosis factor α augments the antigenicity of melanoma cells

D. Morton, D. Hoon, T. Morisaki, 1993, Cancer Immunology, Immunotherapy.

Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccine.

D. Morton, L. Wanek, S. O’Day, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

D. Morton, A. Barth, D. Hoon, 1994, Cancer research.

Augmentation of T‐Cell Response with a Melanoma Cell Vaccine Expressing Specific HLA‐A Antigens

D. Morton, D. Hoon, T. Morisaki, 1993, Annals of the New York Academy of Sciences.

Prolonged survival after complete resection of metastases from intraocular melanoma

D. Morton, X. Ye, He-jing Wang, 2004, Cancer.

Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma: Therapeutic Utility and Implications of Nodal Microanatomy and Molecular Staging for Improving the Accuracy of Detection of Nodal Micrometastases

R. Elashoff, D. Elashoff, R. Turner, 2003, Annals of surgery.

Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.

D. Morton, D. Hoon, T. Morisaki, 1992, Cancer research.

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide.

D. Morton, D. Hoon, L. Foshag, 1990, Cancer research.

Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients

D. Elashoff, D. Hoon, S. Stern, 2020, Cancers.

Association of Surgical Treatment, Systemic Therapy, and Survival in Patients With Abdominal Visceral Melanoma Metastases, 1965-2014: Relevance of Surgical Cure in the Era of Modern Systemic Therapy

A. Bilchik, M. Faries, Devin C. Flaherty, 2017, JAMA surgery.

An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.

S. Raman, S. Love, H. Taylor, 2016, Journal of minimally invasive gynecology.

Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.

A. Gesierich, R. Dummer, R. Scolyer, 2022, JAMA surgery.

Prospective evaluation of the use of antigen-specific immune complexes in predicting the development of recurrent melanoma.

D. Morton, K. Skinner, J. Wong, 1991, Archives of surgery.

Treatment Utilization and Outcomes for Locally Advanced Rectal Cancer in Older Patients.

R. Essner, J. Weiss, Trevan D. Fischer, 2022, JAMA surgery.

Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications

Mathew Chung, D. Allegra, D. M. Rose, 2000, Annals of Surgical Oncology.

Intraoperative lymphatic mapping for early-stage melanoma of the head and neck.

D. Morton, M. Kelley, R. Essner, 1997, American journal of surgery.

Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.

D. Garrison, D. Morton, P. Schmid, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Technical details of intraoperative lymphatic mapping for early stage melanoma.

D L Morton, A. Cochran, D. Morton, 1992, Archives of surgery.

Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II.

S. Stern, J. Ramiscal, Trevan D. Fischer, 2022, Journal of the American College of Surgeons.

Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine.

D. Morton, S. O’Day, X. Ye, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A preclinical model to assess the antigenicity of an HLA‐A2 melanoma cell vaccine

D. Morton, D. Hoon, P. Terasaki, 1993, Cancer.

Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin

Junbao Yang, A. Chan, Delphine J. Lee, 2017, Front. Oncol..

Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit Melanoma

R. Turner, D. Morton, Delphine J. Lee, 2012, Journal of immunotherapy.

Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function

A. Chan, Delphine J. Lee, M. Faries, 2017, Front. Immunol..

Lymphatic mapping and sentinel lymphadenectomy after wide local excision of primary melanoma.

D. Morton, R. Essner, P. Kelemen, 1999, Journal of the American College of Surgeons.

Natural History of Melanoma in 773 Patients with Tumor-Negative Sentinel Lymph Nodes

D. Morton, He-jing Wang, R. Essner, 2007, Annals of Surgical Oncology.

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

Hiroya Takeuchi, R. Turner, D. Hoon, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients

D. Hoon, Kelly K. Chong, T. Oyama, 2015, Oncotarget.

A Comparison of 3 Tumor Markers (MIA, TA90IC, S100B) in Stage III Melanoma Patients

D. Elashoff, D. Morton, X. Ye, 2007, Cancer investigation.

Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness

D L Morton, D. Morton, L. Wanek, 1993, Cancer.

Comparison of blue dye and probe-assisted intraoperative lymphatic mapping in melanoma to identify sentinel nodes in 100 lymphatic basins.

D. Morton, M. Kelley, R. Essner, 1999, Archives of surgery.

Pediatric‐protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcoma

E. Beierle, K. Gow, M. Langer, 2017, Surgery.

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

D. Morton, D. Hoon, B. Taback, 2001, Cancer research.

Testosterone-secreting adrenal adenoma containing crystalloids characteristic of Leydig cells.

L. Foshag, E. Chideckel, C. Boyd, 1985, The American journal of medicine.

The role of surgery in the treatment of nonregionally recurrent melanoma.

D. Morton, K. Skinner, J. Wong, 1993, Surgery.

Focused Examination of Sentinel Lymph Nodes Upstages Early Colorectal Carcinoma

R. Turner, D. Morton, A. Bilchik, 2000, The American surgeon.

Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma.

D. Morton, S. O’Day, R. Essner, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A.

D. Morton, D. Hoon, P. Terasaki, 1992, Cellular immunology.

Is Sentinel Lymph Node Mapping Indicated for Isolated Local and In-Transit Recurrent Melanoma?

D. Morton, L. Wanek, K. Yao, 2003, Annals of surgery.

The expression of the interleukin 4 (IL-4) receptor (IL-4R) and ef facts of human recombinant IL-4 on human gastric carcinoma cell lines

D. Morton, D. Hoon, T. Morisaki, 2006 .

Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease

R. Elashoff, V. Sondak, D. Elashoff, 2019, Annals of Surgical Oncology.

Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival over Five Decades

M. Sim, M. Faries, Ji Hye Lee, 2016, The American surgeon.

Standardized probe-directed sentinel node dissection in melanoma.

D. Morton, R. Essner, E. Glass, 2000, Surgery.

Intraoperative lymphatic mapping and selective lymphadenectomy: 26

Donald L. Morton, Alistair J. Cochran, A. Cochran, 1993 .

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy.

C. Lim, A. Bhagat, S. O’Day, 2019, Clinical chemistry.

Evolving management of early stage pancreatic adenocarcinoma in older patients.

R. Essner, Trevan D. Fischer, M. Goldfarb, 2022, American journal of surgery.

Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments

A. Bilchik, M. Faries, Devin C. Flaherty, 2015, The American surgeon.

Radiofrequency Ablation in 447 Complex Unresectable Liver Tumors: Lessons Learned

D. Allegra, A. Bilchik, Leland J. Foshag, 2003, Annals of Surgical Oncology.

Colorectal Cancer Screening and Surveillance: Current Standards and Future Trends

S. Martinez, A. Bilchik, L. Foshag, 2006, Annals of Surgical Oncology.

Early-stage CCNG1+ HR+ HER2+ Invasive Breast Carcinoma in Older Women: Current Treatment and Future Perspectives for DeltaRex-G, a CCNG1 Inhibitor

F. Hall, Kushal Suryamohan, G. Iyengar, 2023, AntiCancer Research.

Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic Techniques

D. Morton, S. Saha, A. Bilchik, 2001, Annals of Surgical Oncology.

Parotid Region Lymphatic Mapping and Sentinel Lymphadenectomy for Cutaneous Melanoma

D. Morton, R. Essner, D. Ollila, 1999, Annals of Surgical Oncology.

Radiofrequency Ablation: A Novel Primary and Adjunctive Ablative Technique for Hepatic Malignancies

D. Allegra, D. M. Rose, A. Bilchik, 1999, The American surgeon.

Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases

D. Morton, S. Chawla, A. Bilchik, 2002, Annals of Surgical Oncology.

Testosterone-Secreting Adrenal Adenoma Containing Crystalloids Characteristic of Leydig Cells

L. Foshag, E. Chideckel, C. Boyd, 1986 .

Systemic irinotecan or regional floxuridine chemotherapy prolongs survival after hepatic cryosurgery in patients with metastatic colon cancer refractory to 5-fluorouracil.

S. Chawla, A. Bilchik, K. Ramming, 2001, Clinical colorectal cancer.

Interleukin-4 plus tumor necrosis factor alpha augments the antigenicity of melanoma cells.

D. Morton, D. Hoon, T. Morisaki, 1993, Cancer immunology, immunotherapy : CII.